Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Recommendations on RBC Transfusions for Critically Ill Children With Nonhemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.
Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome.
Oligonucleotide therapeutic approaches for Huntington disease.
See All 63 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oligonucleotide therapeutic approaches for Huntington disease.
Sah DW, Aronin N. Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest. 2011 Feb; 121(2):500-7.
View in:
PubMed
subject areas
Clinical Trials as Topic
Gene Silencing
Humans
Huntingtin Protein
Huntington Disease
Mutation
Nerve Tissue Proteins
Neurons
Nuclear Proteins
Oligonucleotides
Oligonucleotides, Antisense
RNA Interference
Trinucleotide Repeat Expansion
authors with profiles
Neil Aronin MD